source
- FDA warns investors that advisory panel reviews do not guarantee drug approval, cites concerns at Capricor and ReplimuneThe FDA issued a reminder to investors that the outcomes of advisory committee meetings are not final decisions on a drug’s fate. This week the agency released briefing documents highlighting conc…
- J&J offers $5.5 billion settlement to resolve talc lawsuitsJohnson & Johnson has put forward a settlement proposal of $5.5 billion to end the litigation over its talc products. The proposal follows more than a decade of legal battles and three unsuccessfu…